source
- Can a chaotic FDA still deliver on faster drug development?As leadership changes create more instability at the FDA, here’s what one former agency official thinks it will take to keep speedier drug approvals on track.BioPharma Dive · 2mo ago↗ source
- STAT+: Pharmalittle: We’re reading about Replimune drug getting third try at FDA approval, a Pfizer deal in China, and morePharma updates from the Pharmalot campus via the Pharmalittle newsletterSTAT · 2mo ago↗ source
- STAT+: Allogene CEO David Chang stepping downPfizer invests billions to buy Chinese drugs, WHO maps experimental response to Ebola outbreak, and other biotech news from The ReadoutSTAT · 2mo ago↗ source